Artemether-Lumefantrine Tablets from Japan
Combination tablets containing artemether and lumefantrine, both antimalarial active principles listed in subheading note 2, put up in measured doses for retail sale. Classified under HTS 3004.60.00.00 as a mixed product for therapeutic use against Plasmodium falciparum malaria. Each pack provides a full adult treatment course.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Obtain FDA approval and ensure NDC labeling for retail packs; verify active ingredients match subheading note 2 list
• Common pitfall: misclassifying as unmixed if not in fixed combo ratio
• Include stability data in documentation